Clinical Trial: Using Plasma HPV Related DNA and RNA to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214584) titled 'Using Plasma HPV Related DNA and RNA to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy' on Oct. 07.

Brief Summary: The goal of this study is to test two commercially available technologies for their ability to detect treatment response in patients with cervical cancer following surgery, radiation, and chemotherapy: one based on PCR (NavDx) and the other on branched DNA (Quantivirus HPV [DNA]). We will perform a 9-month feasibility study to examine the side-by-side utility of both NavDx and Quantivirus HPV DNA assays in predicting cervical cancer treatment response.

We believe these tests could prove to b...